Welcome to the researcher noticeboard. Here you can find information on the latest MND-related news, grant deadlines, awards and meetings. To receive updates on current grants, awards and events relating to MND straight into your inbox, you can subscribe to our quarterly e-newsletter 'The Researcher'.
Grant deadlines and awards
See below for information on MND Association grant deadlines and other grants and awards available to MND/ALS researchers.
The International Eppendorf & Science Prize for Neurobiology is awarded annually to one young scientist for the most outstanding neurobiological research based on methods of molecular and cell biology conducted by him/her during the past three years.
Prize money: US $25,000
Entry deadline for the 2020 Prize: 15 June 2020
The Radala Foundation is looking for established, leading principal investigators eligible for 200,000 CHF research funding to pursue a potentially ground-breaking, high-risk project for 2 years in basic research in ALS. One or two grants of 200,000 Swiss francs will be given each year.
The goal of the foundation is to provide research grants for the study of the understanding of the basic causes of the disease. These awards are not directed to clinically related projects for patient care. There is no geographical limitation to the recipients of these grants. Investigators active in ALS research or in broadly related fields are encouraged to submit proposals relevant to ALS.
Applications can be sent by e-mail before the deadline: 30 June 2020
The Frick Foundation is looking for talented early-career scientists who have already produced excellent supervised work, ready to work independently and shows potential to be a research leader. Two researchers will receive 100,000 Swiss francs each that can be used over 2 years.
Researchers of any nationality with 5 years of experience since completion of their PhD, a scientific track record showing great promise and an excellent research proposal. Research must be conducted in a public or private research organisation (known as a Host Institution/HI).
Applications can be sent by e-mail for the deadline of 30 September 2020.
This Funding Opportunity Announcement invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare disease research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.
Applications are now invited with the next application due dates on 8 June 2020, 26 October 2020, 7 June 2021, 25 October 2021.
Meetings and awards
See below for information on events that might be relevant to you.
In light of the Coronavirus pandemic situation we have decided that we must postpone this event. This is not a decision we have made lightly, but we feel that we must safeguard the health of people affected by MND as a priority.
Location: The Exchange, Colworth Science Park, Sharnbrook, Bedford
This year sees the launch of our Early Career Researcher Workshop & MND Conference, a two-day event set in the beautiful surroundings of Colworth Science Park in Bedfordshire.
We want to recognise the important work being carried out by early career researchers who have chosen MND as their area of investigation. This event is for PhD students and post-doctoral researchers within five years of their PhD (career breaks will be taken into account). It will bring together the brightest minds in MND research with their peers, respected researchers, clinicians and scientists, and people living with or affected by MND, for two days of inspirational talks from keynote speakers and engaging activities.
Location: Edinburgh, Scotland
The European Network for the Cure of ALS (ENCALS) aims to develop a European trial network and initiate collaborations in Europe. Membership is open to Universities/Hospitals in Europe with ALS clinical/research activity.
Their next two-day meeting in 2020 will be held in the University of Edinburgh’s McEwan Hall. Local organisers are Prof. Sharon Abrahams and Prof. Siddharthan Chandran on behalf of the Euan MacDonald Centre for Motor Neurone Disease Research.
Hosted by St Christopher’s and King’s MND Care and Research Centre, this popular annual one day conference will focus on topics including clinical trials update and symptom update.
The conference is aimed at:
- dieticians, occupational therapists, physiotherapists, speech and language therapists,
- clinical nurse specialists, community and district nurses and qualified care home staff
- social workers, counsellors, psychologists and chaplains/spiritual care providers
palliative care practitioners
- other professionals involved in the care of people with MND.
The key to defeating MND lies in fostering strong collaboration between leading researchers around the world, and sharing new understanding of the disease as rapidly as possible. This was the MND Association’s rationale behind the creation of the International Symposium on ALS/MND.
Each year, the Symposium attracts around 1,000 delegates, representing the energy and dynamism of the global MND research community. It is the largest medical and scientific conference specific to MND/ALS and is the premier event in the MND research calendar for discussion on the latest advances in research and clinical management.
As a result of the continuing global uncertainty caused by the Covid-19 pandemic, the MND Association has taken the very difficult decision to cancel this year’s International Symposium on ALS/MND. This follows detailed consultation with the International Alliance of ALS/MND Associations and our 2020 hosts ALS Canada and ALS Quebec.
Our teams are now working hard to create alternative opportunities to exchange the latest exciting advances in research and clinical management and to ensure global collaboration continues. Our current focus is the creation of a Virtual Symposium later this year – we will bring you more details on that over the coming weeks.